Shanghai Kaibao Pharmaceutical Co.,Ltd.’s Net Profit Rose 64.2% in First Half of 2023

Shanghai Kaibao Pharmaceutical Co.,Ltd. (上海凯宝药业股份有限公司) (300039.SZ) reported a net profit of 135.1 million yuan in the first half of 2023, up 64.2% year-on-year.

Meanwhile, the company posted 846.3 million yuan in revenue, up 56.7% year-on-year.

At the end of the reporting period, it had 4.5 billion yuan in total assets and 639.1 million yuan in total liabilities, with a liability-to-asset ratio of 14.1%.